JP2004537540A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004537540A5 JP2004537540A5 JP2003508413A JP2003508413A JP2004537540A5 JP 2004537540 A5 JP2004537540 A5 JP 2004537540A5 JP 2003508413 A JP2003508413 A JP 2003508413A JP 2003508413 A JP2003508413 A JP 2003508413A JP 2004537540 A5 JP2004537540 A5 JP 2004537540A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- dermis
- kit according
- mammal
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 claims 13
- 238000010521 absorption reaction Methods 0.000 claims 6
- 210000004207 dermis Anatomy 0.000 claims 5
- 238000002347 injection Methods 0.000 claims 5
- 239000007924 injection Substances 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 4
- 230000009885 systemic effect Effects 0.000 claims 4
- 229940098778 Dopamine receptor agonist Drugs 0.000 claims 3
- 102000018997 Growth Hormone Human genes 0.000 claims 3
- 108010051696 Growth Hormone Proteins 0.000 claims 3
- 239000003136 dopamine receptor stimulating agent Substances 0.000 claims 3
- 238000004520 electroporation Methods 0.000 claims 3
- 239000000122 growth hormone Substances 0.000 claims 3
- 239000003055 low molecular weight heparin Substances 0.000 claims 3
- 229940127215 low-molecular weight heparin Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/897,801 US20030073609A1 (en) | 2001-06-29 | 2001-06-29 | Enhanced pharmacokinetic profile of intradermally delivered substances |
| PCT/US2001/050862 WO2003002175A2 (fr) | 2001-06-29 | 2001-12-26 | Profil pharmacocinetique ameliore de substances administrees par voie intradermique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004537540A JP2004537540A (ja) | 2004-12-16 |
| JP2004537540A5 true JP2004537540A5 (fr) | 2005-12-22 |
Family
ID=25408438
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003508413A Withdrawn JP2004537540A (ja) | 2001-06-29 | 2001-12-26 | 真皮内送達物質の全身吸収増大 |
| JP2003508333A Withdrawn JP2005503359A (ja) | 2001-06-29 | 2002-06-24 | 疎水性物質の薬物動態学的プロファイルの増大 |
| JP2003508342A Withdrawn JP2005502613A (ja) | 2001-06-29 | 2002-06-24 | 疎水性ドーパミン作動薬の真皮への投与 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003508333A Withdrawn JP2005503359A (ja) | 2001-06-29 | 2002-06-24 | 疎水性物質の薬物動態学的プロファイルの増大 |
| JP2003508342A Withdrawn JP2005502613A (ja) | 2001-06-29 | 2002-06-24 | 疎水性ドーパミン作動薬の真皮への投与 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US20030073609A1 (fr) |
| EP (3) | EP1399205A2 (fr) |
| JP (3) | JP2004537540A (fr) |
| KR (3) | KR20040022438A (fr) |
| CN (3) | CN1610567A (fr) |
| AU (1) | AU2002345813B2 (fr) |
| BR (2) | BR0210665A (fr) |
| CA (3) | CA2450354A1 (fr) |
| CO (2) | CO5540369A2 (fr) |
| CZ (3) | CZ20033059A3 (fr) |
| EA (3) | EA006922B1 (fr) |
| IL (3) | IL158651A0 (fr) |
| MX (3) | MXPA03011931A (fr) |
| NO (3) | NO20035580D0 (fr) |
| PL (3) | PL365667A1 (fr) |
| WO (3) | WO2003002175A2 (fr) |
| ZA (3) | ZA200308385B (fr) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69926053T2 (de) | 1999-04-27 | 2006-04-27 | Transgene S.A. | Verfahren zur Herstellung von Säugetier-Zellinien |
| US8465468B1 (en) | 2000-06-29 | 2013-06-18 | Becton, Dickinson And Company | Intradermal delivery of substances |
| US20020095134A1 (en) * | 1999-10-14 | 2002-07-18 | Pettis Ronald J. | Method for altering drug pharmacokinetics based on medical delivery platform |
| US20020156453A1 (en) * | 1999-10-14 | 2002-10-24 | Pettis Ronald J. | Method and device for reducing therapeutic dosage |
| US20040175360A1 (en) * | 2000-06-29 | 2004-09-09 | Pettis Ronald J. | Method for altering drug pharmacokinetics based on medical delivery platform |
| US20050008683A1 (en) * | 2000-06-29 | 2005-01-13 | Becton Dickinson And Company | Method for delivering interferons to the intradermal compartment |
| DE10053397A1 (de) | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
| DE10066158B4 (de) * | 2000-08-24 | 2007-08-09 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms |
| DE10064453A1 (de) * | 2000-12-16 | 2002-07-04 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
| JP2004525713A (ja) * | 2001-04-13 | 2004-08-26 | ベクトン・ディキンソン・アンド・カンパニー | 全身吸収のために皮膚の皮内層中に物質を投与するための方法および装置 |
| WO2003002069A2 (fr) * | 2001-06-29 | 2003-01-09 | Becton, Dickinson And Company | Distribution intradermique de vaccins et d'agents therapeutiques geniques via une microcannule |
| US20050010193A1 (en) * | 2002-05-06 | 2005-01-13 | Laurent Philippe E. | Novel methods for administration of drugs and devices useful thereof |
| US20030073609A1 (en) * | 2001-06-29 | 2003-04-17 | Pinkerton Thomas C. | Enhanced pharmacokinetic profile of intradermally delivered substances |
| US20040120964A1 (en) * | 2001-10-29 | 2004-06-24 | Mikszta John A. | Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
| US7722595B2 (en) * | 2002-05-06 | 2010-05-25 | Becton, Dickinson And Company | Method and device for controlling drug pharmacokinetics |
| US20060264886A9 (en) * | 2002-05-06 | 2006-11-23 | Pettis Ronald J | Method for altering insulin pharmacokinetics |
| BR0313890A (pt) * | 2002-08-30 | 2005-07-26 | Becton Dickinson Co | Método de controle da farmacocinética de compostos imunomoduladores |
| CN1859943B (zh) * | 2002-10-11 | 2010-09-29 | 贝克顿·迪金森公司 | 用于控制患者体内葡萄糖的浓度的系统 |
| US20050163711A1 (en) * | 2003-06-13 | 2005-07-28 | Becton, Dickinson And Company, Inc. | Intra-dermal delivery of biologically active agents |
| US7318925B2 (en) | 2003-08-08 | 2008-01-15 | Amgen Fremont, Inc. | Methods of use for antibodies against parathyroid hormone |
| CN1838968A (zh) | 2003-08-08 | 2006-09-27 | 艾伯吉尼斯公司 | 针对甲状旁腺激素(pth)之抗体和其用途 |
| BRPI0413539B8 (pt) | 2003-08-12 | 2021-06-22 | Becton Dickinson Co | dispositivo para distribuir medicamento para o corpo de um paciente por injeção |
| EP1658078A4 (fr) * | 2003-08-26 | 2009-05-06 | Becton Dickinson Co | Procedes d'administration intradermique d'agents therapeutiques |
| US20050256499A1 (en) * | 2004-03-03 | 2005-11-17 | Pettis Ronald J | Methods and devices for improving delivery of a substance to skin |
| WO2005115360A2 (fr) * | 2004-05-11 | 2005-12-08 | Becton, Dickinson And Company | Formulations de substances analgesiques et leurs methodes d'administration |
| US7806854B2 (en) * | 2005-05-13 | 2010-10-05 | Trustees Of Boston University | Fully automated control system for type 1 diabetes |
| US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
| US8197435B2 (en) | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
| US8025634B1 (en) * | 2006-09-18 | 2011-09-27 | Baxter International Inc. | Method and system for controlled infusion of therapeutic substances |
| JP5731120B2 (ja) * | 2007-03-19 | 2015-06-10 | インスライン メディカル エルティーディー． | 薬剤送達器具 |
| WO2008114220A2 (fr) * | 2007-03-19 | 2008-09-25 | Insuline Medical Ltd. | Dispositif d'administration de médicament et connexions associées à celui-ci |
| US8622991B2 (en) | 2007-03-19 | 2014-01-07 | Insuline Medical Ltd. | Method and device for drug delivery |
| US9220837B2 (en) | 2007-03-19 | 2015-12-29 | Insuline Medical Ltd. | Method and device for drug delivery |
| WO2008115586A1 (fr) * | 2007-03-21 | 2008-09-25 | Alza Corporation | Appareil et procédé d'administration transdermique d'un agoniste de triptane |
| US8642062B2 (en) | 2007-10-31 | 2014-02-04 | Abbott Cardiovascular Systems Inc. | Implantable device having a slow dissolving polymer |
| EP2478893B8 (fr) * | 2007-11-29 | 2013-10-09 | AllTranz Inc. | Procédés et compositions permettant d'accroitre la durabilité de pores créés par des micro-aiguilles |
| EP2231229A1 (fr) | 2007-12-18 | 2010-09-29 | Insuline Medical Ltd. | Dispositif d'administration de médicament doté d'un capteur pour un fonctionnement en boucle fermée |
| MX2011004817A (es) | 2008-11-07 | 2011-07-28 | Insuline Medical Ltd | Dispositivo y metodo para suministrar farmacos. |
| US7828996B1 (en) | 2009-03-27 | 2010-11-09 | Abbott Cardiovascular Systems Inc. | Method for the manufacture of stable, nano-sized particles |
| US9199034B2 (en) * | 2009-11-09 | 2015-12-01 | Becton, Dickinson And Company | Drug delivery devices, systems, and methods |
| KR100967900B1 (ko) * | 2010-04-12 | 2010-07-06 | 대전광역시 | 교차로 정보제공 시스템 |
| CN103327939B (zh) | 2010-10-15 | 2017-05-24 | 科尼尔赛德生物医学公司 | 用于进入眼睛的装置 |
| JP6047097B2 (ja) | 2010-10-31 | 2016-12-21 | トラスティーズ オブ ボストン ユニバーシティ | 血糖制御システム |
| ES3023054T3 (en) | 2012-11-08 | 2025-05-29 | Clearside Biomedical Inc | Methods for the treatment of ocular disease in human subjects |
| MX372859B (es) | 2013-05-03 | 2020-07-07 | Clearside Biomedical Inc | Aparatos y métodos para inyección ocular. |
| EP3003454B1 (fr) | 2013-06-03 | 2020-01-08 | Clearside Biomedical, Inc. | Appareil pour une administration de médicament à l'aide de multiples réservoirs |
| MX373076B (es) | 2014-01-31 | 2020-07-06 | Univ Boston | Control de nivel de glucosa fuera de línea basado en periodos anteriores de control de nivel de glucosa en línea. |
| RU2710491C2 (ru) | 2014-06-20 | 2019-12-26 | Клиасайд Байомедикал, Инк. | Устройство для инъекции лекарственного средства в глазную ткань и способ инъекции лекарственного средства в глазную ткань |
| MX384044B (es) * | 2015-05-28 | 2025-03-14 | Dr Reddy´S Laboratories Ltd | Composicion oral de celecoxib para tratamiento de dolor. |
| EP3319511B1 (fr) | 2015-08-07 | 2021-10-06 | Trustees of Boston University | Système de régulation de glucose à adaptation automatique de cible de glucose |
| EP3413851B1 (fr) | 2016-02-10 | 2023-09-27 | Clearside Biomedical, Inc. | Emballage |
| CA3062845A1 (fr) | 2016-05-02 | 2017-11-09 | Clearside Biomedical, Inc. | Systemes et methodes pour l'administration de medicaments par voie ophtalmique |
| IL305537B2 (en) | 2016-08-12 | 2025-02-01 | Clearside Biomedical Inc | Devices and methods for adjusting the insertion depth of a needle for administering a drug |
| WO2018204515A1 (fr) | 2017-05-02 | 2018-11-08 | Georgia Tech Research Corporation | Procédés d'administration ciblée de médicament au moyen d'une microaiguille |
| JP7682453B2 (ja) | 2019-07-16 | 2025-05-26 | ベータ バイオニクス，インコーポレイテッド | 血糖制御システム |
| US11957876B2 (en) | 2019-07-16 | 2024-04-16 | Beta Bionics, Inc. | Glucose control system with automated backup therapy protocol generation |
| WO2021011697A1 (fr) | 2019-07-16 | 2021-01-21 | Beta Bionics, Inc. | Système de contrôle de la glycémie |
| WO2022144590A1 (fr) | 2020-12-28 | 2022-07-07 | Dr. Reddy's Laboratories Ltd. | Célécoxib pour le traitement de la douleur |
| US12465686B2 (en) | 2021-03-25 | 2025-11-11 | Beta Bionics, Inc. | Emergency medicament dose control |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2619962A (en) * | 1948-02-19 | 1952-12-02 | Res Foundation | Vaccination appliance |
| US3964482A (en) * | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
| BE795384A (fr) * | 1972-02-14 | 1973-08-13 | Ici Ltd | Pansements |
| US4270537A (en) * | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
| IE53703B1 (en) * | 1982-12-13 | 1989-01-18 | Elan Corp Plc | Drug delivery device |
| US4826689A (en) | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
| CA1283827C (fr) * | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Dispositif pour l'injection de formules liquides |
| US6056716A (en) * | 1987-06-08 | 2000-05-02 | D'antonio Consultants International Inc. | Hypodermic fluid dispenser |
| AU614092B2 (en) * | 1987-09-11 | 1991-08-22 | Paul Max Grinwald | Improved method and apparatus for enhanced drug permeation of skin |
| IT1227626B (it) | 1988-11-28 | 1991-04-23 | Vectorpharma Int | Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione |
| US5273975A (en) * | 1989-06-09 | 1993-12-28 | The Upjohn Company | Heterocyclic amines having central nervous system activity |
| US5098389A (en) * | 1990-06-28 | 1992-03-24 | Becton, Dickinson And Company | Hypodermic needle assembly |
| US5527288A (en) * | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
| US5156591A (en) * | 1990-12-13 | 1992-10-20 | S. I. Scientific Innovations Ltd. | Skin electrode construction and transdermal drug delivery device utilizing same |
| US5279544A (en) * | 1990-12-13 | 1994-01-18 | Sil Medics Ltd. | Transdermal or interdermal drug delivery devices |
| TW279133B (fr) * | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
| SE9102652D0 (sv) * | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
| US5298262A (en) | 1992-12-04 | 1994-03-29 | Sterling Winthrop Inc. | Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
| US5346702A (en) | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| US5336507A (en) | 1992-12-11 | 1994-08-09 | Sterling Winthrop Inc. | Use of charged phospholipids to reduce nanoparticle aggregation |
| US5279552A (en) * | 1993-01-11 | 1994-01-18 | Anton Magnet | Intradermal injection device |
| CA2132277C (fr) * | 1993-10-22 | 2005-05-10 | Giorgio Cirelli | Dispositif d'injection |
| US5997501A (en) * | 1993-11-18 | 1999-12-07 | Elan Corporation, Plc | Intradermal drug delivery device |
| US5591139A (en) * | 1994-06-06 | 1997-01-07 | The Regents Of The University Of California | IC-processed microneedles |
| US5582591A (en) * | 1994-09-02 | 1996-12-10 | Delab | Delivery of solid drug compositions |
| IE72524B1 (en) * | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| US5983130A (en) * | 1995-06-07 | 1999-11-09 | Alza Corporation | Electrotransport agent delivery method and apparatus |
| US5801057A (en) * | 1996-03-22 | 1998-09-01 | Smart; Wilson H. | Microsampling device and method of construction |
| US6576636B2 (en) * | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
| IL127328A (en) * | 1996-06-10 | 2003-07-31 | Elan Corp Plc | Needle for subcutaneous delivery of fluids |
| US5871158A (en) * | 1997-01-27 | 1999-02-16 | The University Of Utah Research Foundation | Methods for preparing devices having metallic hollow microchannels on planar substrate surfaces |
| US5783705A (en) * | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
| US5928207A (en) * | 1997-06-30 | 1999-07-27 | The Regents Of The University Of California | Microneedle with isotropically etched tip, and method of fabricating such a device |
| IE970782A1 (en) * | 1997-10-22 | 1999-05-05 | Elan Corp | An improved automatic syringe |
| US5957895A (en) * | 1998-02-20 | 1999-09-28 | Becton Dickinson And Company | Low-profile automatic injection device with self-emptying reservoir |
| CA2331532A1 (fr) * | 1998-05-08 | 1999-11-18 | Genetronics, Inc. | Vasodilatation d'un vaisseau induite electriquement |
| JP2002517300A (ja) * | 1998-06-10 | 2002-06-18 | ジョージア テック リサーチ コーポレイション | 微小針デバイスおよび製造方法ならびにそれらの使用 |
| US6503231B1 (en) * | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
| US6589987B2 (en) * | 1998-09-08 | 2003-07-08 | Charlotte-Mecklenburg Hospital Authority | Method of treating cancer using tetraethyl thiuram disulfide |
| US6455564B1 (en) | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
| ATE462468T1 (de) * | 1999-06-04 | 2010-04-15 | Georgia Tech Res Inst | Vorrichtungen zur vergrösserten penetration von mikronadeln in biologischen hautschichten |
| DE19938823A1 (de) * | 1999-08-19 | 2001-02-22 | Boehringer Ingelheim Pharma | Medikamentöse Behandlung des Restless Leg Syndroms |
| US6319224B1 (en) * | 1999-08-20 | 2001-11-20 | Bioject Medical Technologies Inc. | Intradermal injection system for injecting DNA-based injectables into humans |
| US7113821B1 (en) * | 1999-08-25 | 2006-09-26 | Johnson & Johnson Consumer Companies, Inc. | Tissue electroperforation for enhanced drug delivery |
| US6776776B2 (en) * | 1999-10-14 | 2004-08-17 | Becton, Dickinson And Company | Prefillable intradermal delivery device |
| US6843781B2 (en) * | 1999-10-14 | 2005-01-18 | Becton, Dickinson And Company | Intradermal needle |
| US20020095134A1 (en) * | 1999-10-14 | 2002-07-18 | Pettis Ronald J. | Method for altering drug pharmacokinetics based on medical delivery platform |
| US6569143B2 (en) * | 1999-10-14 | 2003-05-27 | Becton, Dickinson And Company | Method of intradermally injecting substances |
| WO2001037882A2 (fr) * | 1999-11-24 | 2001-05-31 | Elan Pharmaceuticals, Inc. | Technique et composition permettant de se proteger contre les pathologies renales induites par le milieu destine a contraster les radiographies |
| DE10001785A1 (de) * | 2000-01-18 | 2001-07-19 | Boehringer Ingelheim Pharma | NK¶1¶-Rezeptor-Antagonisten zur Behandlung des Restless Legs Syndroms |
| WO2003002069A2 (fr) * | 2001-06-29 | 2003-01-09 | Becton, Dickinson And Company | Distribution intradermique de vaccins et d'agents therapeutiques geniques via une microcannule |
| US20030073609A1 (en) * | 2001-06-29 | 2003-04-17 | Pinkerton Thomas C. | Enhanced pharmacokinetic profile of intradermally delivered substances |
-
2001
- 2001-06-29 US US09/897,801 patent/US20030073609A1/en not_active Abandoned
- 2001-12-26 MX MXPA03011931A patent/MXPA03011931A/es not_active Application Discontinuation
- 2001-12-26 PL PL01365667A patent/PL365667A1/xx not_active Application Discontinuation
- 2001-12-26 CZ CZ20033059A patent/CZ20033059A3/cs unknown
- 2001-12-26 EA EA200301307A patent/EA006922B1/ru not_active IP Right Cessation
- 2001-12-26 WO PCT/US2001/050862 patent/WO2003002175A2/fr not_active Ceased
- 2001-12-26 JP JP2003508413A patent/JP2004537540A/ja not_active Withdrawn
- 2001-12-26 KR KR10-2003-7017079A patent/KR20040022438A/ko not_active Withdrawn
- 2001-12-26 EP EP01991616A patent/EP1399205A2/fr not_active Withdrawn
- 2001-12-26 CN CNA018234062A patent/CN1610567A/zh active Pending
- 2001-12-26 IL IL15865101A patent/IL158651A0/xx unknown
- 2001-12-26 CA CA002450354A patent/CA2450354A1/fr not_active Abandoned
-
2002
- 2002-06-24 CZ CZ20033363A patent/CZ20033363A3/cs unknown
- 2002-06-24 CN CNA028131746A patent/CN1522139A/zh active Pending
- 2002-06-24 JP JP2003508333A patent/JP2005503359A/ja not_active Withdrawn
- 2002-06-24 EP EP02753349A patent/EP1416915A1/fr not_active Ceased
- 2002-06-24 KR KR10-2003-7017082A patent/KR20040019024A/ko not_active Withdrawn
- 2002-06-24 JP JP2003508342A patent/JP2005502613A/ja not_active Withdrawn
- 2002-06-24 AU AU2002345813A patent/AU2002345813B2/en not_active Expired - Fee Related
- 2002-06-24 CN CNA028130502A patent/CN1723052A/zh active Pending
- 2002-06-24 CA CA002452393A patent/CA2452393A1/fr not_active Abandoned
- 2002-06-24 CA CA002452321A patent/CA2452321A1/fr not_active Abandoned
- 2002-06-24 IL IL15902402A patent/IL159024A0/xx unknown
- 2002-06-24 MX MXPA03011710A patent/MXPA03011710A/es unknown
- 2002-06-24 KR KR10-2003-7017081A patent/KR20040029327A/ko not_active Withdrawn
- 2002-06-24 US US10/480,973 patent/US20040170654A1/en not_active Abandoned
- 2002-06-24 WO PCT/US2002/020080 patent/WO2003002094A2/fr not_active Ceased
- 2002-06-24 US US10/480,975 patent/US20040175401A1/en not_active Abandoned
- 2002-06-24 CZ CZ20033364A patent/CZ20033364A3/cs unknown
- 2002-06-24 BR BR0210665-5A patent/BR0210665A/pt not_active IP Right Cessation
- 2002-06-24 BR BR0210688-4A patent/BR0210688A/pt not_active IP Right Cessation
- 2002-06-24 EA EA200301308A patent/EA006578B1/ru not_active IP Right Cessation
- 2002-06-24 PL PL02366370A patent/PL366370A1/xx unknown
- 2002-06-24 MX MXPA03011794A patent/MXPA03011794A/es unknown
- 2002-06-24 IL IL15902502A patent/IL159025A0/xx unknown
- 2002-06-24 EP EP02744560A patent/EP1399206A2/fr not_active Withdrawn
- 2002-06-24 WO PCT/US2002/019918 patent/WO2003002103A2/fr not_active Ceased
- 2002-06-24 EA EA200301309A patent/EA006961B1/ru unknown
- 2002-06-24 PL PL02366635A patent/PL366635A1/xx not_active Application Discontinuation
-
2003
- 2003-05-22 US US10/443,361 patent/US20040028707A1/en not_active Abandoned
- 2003-10-28 ZA ZA200308385A patent/ZA200308385B/en unknown
- 2003-11-24 ZA ZA200309125A patent/ZA200309125B/en unknown
- 2003-11-25 ZA ZA200309151A patent/ZA200309151B/en unknown
- 2003-12-15 NO NO20035580A patent/NO20035580D0/no not_active Application Discontinuation
- 2003-12-19 NO NO20035731A patent/NO20035731L/no not_active Application Discontinuation
- 2003-12-22 NO NO20035782A patent/NO20035782L/no not_active Application Discontinuation
- 2003-12-24 CO CO03112352A patent/CO5540369A2/es not_active Application Discontinuation
- 2003-12-24 CO CO03112342A patent/CO5640074A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004537540A5 (fr) | ||
| Zhang et al. | Advances in transdermal insulin delivery | |
| US7722595B2 (en) | Method and device for controlling drug pharmacokinetics | |
| JP2005503359A5 (fr) | ||
| WO2003002175A3 (fr) | Profil pharmacocinetique ameliore de substances administrees par voie intradermique | |
| ECSP056076A (es) | Sistema de suministro para droga y terapia celular | |
| WO2003047663A3 (fr) | Injecteur automatique | |
| EP2422798A3 (fr) | Compositions comprenant des cellules souches embryonnaires humaines et leurs dérivés, procédés d'utilisation et procédés de préparation | |
| SI2926847T1 (sl) | Implantabilna infuzijska naprava s premakljivo in izvlečno iglo | |
| DE60003803D1 (de) | Trockene formbare arzneistoffformulierung | |
| CY1109235T1 (el) | Συνθεσεις χορηγησης φαρμακου αμεσης δρασης | |
| JP2006511582A5 (fr) | ||
| WO2004064889A3 (fr) | Administration cellulaire intradermique au moyen d'une micro-cannule de faible calibre | |
| WO2007073486A3 (fr) | Procedes et compositions pour l'administration d'agents actifs a proprietes pharmacologiques ameliorees | |
| DE60037531D1 (de) | Medikamentenkartusche und injektionsvorrichtung | |
| KR102497984B1 (ko) | 마이크로 니들 제제 및 마이크로 니들 제제의 제조 방법 | |
| WO2006079641A3 (fr) | Derives d'insuline conjugues avec des polymeres ramifies structurellement bien definis | |
| Sadrzadeh et al. | Peptide drug delivery strategies for the treatment of diabetes | |
| JP2011500252A (ja) | 極微針付き医療注射器具 | |
| CN106422046A (zh) | 射流微针注射系统 | |
| JP2005537054A5 (fr) | ||
| CN209475298U (zh) | 一种口腔注射器辅助推进装置 | |
| WO2007084313A3 (fr) | Administration transdermique de médicaments résistante à l'abus | |
| WO2011130663A3 (fr) | Système d'injection utilisé pour l'administration à distance d'agents de charge de tissus mous contenant des microsphères | |
| JP2010510218A5 (fr) |